DK0733621T3 - Hidtil ukendte imidazolderivater og fremgangsmåde til fremstilling af disse - Google Patents

Hidtil ukendte imidazolderivater og fremgangsmåde til fremstilling af disse

Info

Publication number
DK0733621T3
DK0733621T3 DK95902285T DK95902285T DK0733621T3 DK 0733621 T3 DK0733621 T3 DK 0733621T3 DK 95902285 T DK95902285 T DK 95902285T DK 95902285 T DK95902285 T DK 95902285T DK 0733621 T3 DK0733621 T3 DK 0733621T3
Authority
DK
Denmark
Prior art keywords
group
lower alkyl
alkyl group
imidazole derivatives
substituent
Prior art date
Application number
DK95902285T
Other languages
English (en)
Inventor
Hiroyuki Miyachi
Kei Okazaki
Hiromi Kiyota
Mitsuru Segawa
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of DK0733621T3 publication Critical patent/DK0733621T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK95902285T 1993-12-10 1994-12-01 Hidtil ukendte imidazolderivater og fremgangsmåde til fremstilling af disse DK0733621T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34146793 1993-12-10
JP31935594A JP3294961B2 (ja) 1993-12-10 1994-11-29 新規イミダゾール誘導体及びその製造法
PCT/JP1994/002021 WO1995015951A1 (fr) 1993-12-10 1994-12-01 Nouveau derive de l'imidazole et sa methode d'obtention

Publications (1)

Publication Number Publication Date
DK0733621T3 true DK0733621T3 (da) 2002-09-09

Family

ID=26569693

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95902285T DK0733621T3 (da) 1993-12-10 1994-12-01 Hidtil ukendte imidazolderivater og fremgangsmåde til fremstilling af disse

Country Status (15)

Country Link
US (2) US5932607A (da)
EP (1) EP0733621B1 (da)
JP (1) JP3294961B2 (da)
KR (1) KR100362794B1 (da)
CN (2) CN1069098C (da)
AT (1) ATE217614T1 (da)
AU (1) AU680572B2 (da)
CA (1) CA2178604C (da)
DE (1) DE69430636T2 (da)
DK (1) DK0733621T3 (da)
ES (1) ES2176311T3 (da)
HU (1) HU221950B1 (da)
PT (1) PT733621E (da)
TW (1) TW304193B (da)
WO (1) WO1995015951A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE205490T1 (de) * 1995-10-13 2001-09-15 Banyu Pharma Co Ltd Substituierte heteroaromatische derivate
PE92198A1 (es) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
CA2303385A1 (en) * 1997-09-18 1999-03-25 Mitsubishi-Tokyo Pharmaceuticals, Inc. Imidazoline compounds
TW407153B (en) * 1997-10-27 2000-10-01 Nippon Kayaku Kk Imidazole compounds and their use
JP2003286266A (ja) * 1999-03-24 2003-10-10 Mitsubishi-Tokyo Pharmaceuticals Inc イミダゾール化合物
AU1304501A (en) * 1999-11-11 2001-06-06 Kyorin Pharmaceutical Co. Ltd. Oral solid preparation
WO2003027060A1 (fr) * 2001-09-20 2003-04-03 Kyorin Pharmaceutical Co., Ltd. Derives amide de diphenylbutane
JP5087059B2 (ja) * 2001-10-31 2012-11-28 杏林製薬株式会社 4−(2−メチル−1−イミダゾリル)−2,2−ジフェニルブタンアミドの製造方法
CN100364990C (zh) * 2002-10-30 2008-01-30 施万制药 取代的4-氨基-1-(吡啶甲基)哌啶和相关化合物
KR101175816B1 (ko) 2003-08-04 2012-08-24 교린 세이야꾸 가부시키 가이샤 경구 서방성 정제
EP1652523A4 (en) * 2003-08-04 2008-11-19 Kyorin Seiyaku Kk PREPARATION FOR TRANSDERMAL ABSORPTION
EA013689B1 (ru) * 2003-10-14 2010-06-30 Глэксо Груп Лимитед Антагонисты мускариновых ацетилхолиновых рецепторов
PE20050489A1 (es) * 2003-11-04 2005-09-02 Glaxo Group Ltd Antagonistas de receptores de acetilcolina muscarinicos
US7598267B2 (en) * 2004-05-13 2009-10-06 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
EP1845091A4 (en) * 2004-12-14 2009-03-04 Kyorin Seiyaku Kk METHOD FOR PRODUCING AN ANTAGONIST OF THE MUSCARIN RECEPTOR AND INTERMEDIATE PRODUCTS THEREFOR
EP1844773A4 (en) * 2005-02-03 2010-04-28 Kyorin Seiyaku Kk PREPARATION FOR PERCUTANEOUS ABSORPTION
EP1939183A4 (en) * 2005-07-25 2009-02-18 Mitsubishi Tanabe Pharma Corp NOVEL HETEROCYCLIC NITROGEN COMPOUND
CN101983055B (zh) 2008-01-31 2013-05-08 杏林制药株式会社 以咪达那新为有效成分的口腔内速崩片的制造方法
WO2009096560A1 (ja) 2008-01-31 2009-08-06 Kyorin Pharmaceutical Co., Ltd. イミダフェナシン含有口腔内速崩壊性錠剤
WO2010113952A1 (ja) * 2009-03-31 2010-10-07 杏林製薬株式会社 ムスカリン受容体拮抗薬
ES2604705T3 (es) 2010-03-31 2017-03-08 Ono Pharmaceutical Co., Ltd. Agente preventivo y/o remedio para el síndrome mano-pie
CA2796877A1 (en) 2010-04-30 2011-11-03 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
CN102746235B (zh) * 2012-07-20 2014-09-03 北京科莱博医药开发有限责任公司 一种改进的制备咪达那新的方法
CN103242214B (zh) * 2013-05-02 2016-04-06 陕西步长高新制药有限公司 一种吲哚衍生物及其制备方法
CN103242230B (zh) * 2013-05-02 2015-02-18 陕西步长高新制药有限公司 一种喹啉酮衍生物及其制备方法
CN112774569B (zh) * 2021-01-11 2022-04-08 江门市华熊新材料有限公司 含氟咪唑表面活性剂及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073921A (en) * 1975-03-12 1978-02-14 Rohm And Haas Company Substituted arylcyanoalkyl and diarylcyanoalkylimidazoles and fungical compositions and methods utilizing them
US4225723A (en) * 1975-03-12 1980-09-30 Rohm And Haas Company Process for the preparation of substituted arylcyanoalkyl and diaryl cyanoalkylimidazoles
GB2016452B (en) * 1978-02-18 1982-07-21 Kissei Pharmaceutical Imidazole compounds
JPS6019750B2 (ja) * 1978-02-18 1985-05-17 キツセイ薬品工業株式会社 N↓−(ω↓−置換アルキル)イミダゾ−ル
JPS6054307B2 (ja) * 1978-06-09 1985-11-29 小野薬品工業株式会社 イミダゾ−ル誘導体
US4293561A (en) * 1979-03-09 1981-10-06 Syntex (U.S.A.) Inc. 1-(Naphthyl-n-propyl)imidazole derivatives
JPS5756464A (en) * 1980-09-22 1982-04-05 Ono Pharmaceut Co Ltd Imidazole derivative ahd inhibitor for biosyntesis of thromboxane a2
US4766140A (en) * 1984-06-18 1988-08-23 Eli Lilly And Company Method of inhibiting aromatase
US4605661A (en) * 1984-06-18 1986-08-12 Eli Lilly And Company Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
GB8810067D0 (en) * 1988-04-28 1988-06-02 Ucb Sa Substituted 1-(1h-imidazol-4-yl)alkyl-benzamides
JPH06112670A (ja) * 1992-09-24 1994-04-22 Mitsubishi Rayon Co Ltd 電気機器組立方法

Also Published As

Publication number Publication date
ATE217614T1 (de) 2002-06-15
CN1109674C (zh) 2003-05-28
KR100362794B1 (ko) 2003-01-29
CN1258673A (zh) 2000-07-05
CA2178604A1 (en) 1995-06-15
DE69430636T2 (de) 2003-01-02
JP3294961B2 (ja) 2002-06-24
AU1120095A (en) 1995-06-27
DE69430636D1 (de) 2002-06-20
TW304193B (da) 1997-05-01
US6103747A (en) 2000-08-15
WO1995015951A1 (fr) 1995-06-15
CN1069098C (zh) 2001-08-01
ES2176311T3 (es) 2002-12-01
EP0733621B1 (en) 2002-05-15
CA2178604C (en) 2004-06-29
US5932607A (en) 1999-08-03
EP0733621A4 (en) 1997-04-02
AU680572B2 (en) 1997-07-31
HUT74182A (en) 1996-11-28
PT733621E (pt) 2002-09-30
CN1137270A (zh) 1996-12-04
EP0733621A1 (en) 1996-09-25
HU9601505D0 (en) 1996-07-29
HU221950B1 (hu) 2003-03-28
KR960706477A (ko) 1996-12-09
JPH07215943A (ja) 1995-08-15

Similar Documents

Publication Publication Date Title
DK0733621T3 (da) Hidtil ukendte imidazolderivater og fremgangsmåde til fremstilling af disse
DK1026147T3 (da) Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater
ATE126219T1 (de) Benzimidazolderivate, verfahren zu deren herstellung und anwendung.
DE69824194D1 (de) Substituierte kondensierte heterocyclische verbindungen
DE69613240T2 (de) N-aminoalkylfluorencarboxamide, neue klasse von dopaminerezeptor subtype spezifische liganden
DE69824332D1 (de) N-Aryl-piperidinderivate und ihre Verwendung als 5-HT1B-Rezeptorliganden
TW231258B (da)
DK0868182T3 (da) Fremgangsmåde til fremstilling af piperidinderivater
ATE268330T1 (de) Azaidole mit serotonin rezeptor affinität
DK1026167T3 (da) Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler
DK0802185T3 (da) Fremgangsmåde til fremstilling af piperidincarbinoler
ES2126693T3 (es) Derivado de triazina, su produccion y su uso.
ES2120498T3 (es) Nuevo compuesto tetraciclico.
DE69915471D1 (de) Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
DK0787710T3 (da) Fluorpropenforbindelse, et insekticid indeholdende samme og et mellemprodukt til fremstilling deraf
DE69017627D1 (de) Isochinolinderivate und ihre Salze als Proteasehemmer.
BR9812928B1 (pt) derivados de 3-oxo-(2h)-1,2,4-triazina, compostos, processo de preparaÇço de compostos quÍmicos, e, composiÇço farmacÊutica.
AU7332996A (en) Therapeutics for thrombocytopenia
ES2024332A6 (es) Procedimiento para la obtencion de nuevas sulfonamidas.
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel
KR920000707A (ko) 제초성 화합물
EP1340753A4 (en) CARBAMATE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
MY104164A (en) Heterocyclic compounds.
TH28100B (th) สารประกอบไพแรโนนซึ่งมีประโยชน์สำหรับใช้รักษาโรคติดเชื้อรีโทรไวรัส